-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ECz1lNBjA5K49MMeFPsF/OBiOvdBMprMc4Vz1IN5lIltPthmxoQODeJfNLO8wQHB +0f1l9GV5/iRPupm9l5uTQ== 0000950131-00-002156.txt : 20000411 0000950131-00-002156.hdr.sgml : 20000411 ACCESSION NUMBER: 0000950131-00-002156 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20000319 FILED AS OF DATE: 20000329 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: WESLEY JESSEN VISIONCARE INC CENTRAL INDEX KEY: 0001027584 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 364023739 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: SEC FILE NUMBER: 000-22033 FILM NUMBER: 583474 BUSINESS ADDRESS: STREET 1: 333 EAST HOWARD AVE CITY: DES PLAINES STATE: IL ZIP: 60018-5903 BUSINESS PHONE: 8472943000 MAIL ADDRESS: STREET 1: 333 EAST HOWARD AVE CITY: DES PLAINES STATE: IL ZIP: 60018-5903 FORMER COMPANY: FORMER CONFORMED NAME: WESLEY JESSEN HOLDING INC DATE OF NAME CHANGE: 19961126 COMPANY DATA: COMPANY CONFORMED NAME: OCULAR SCIENCES INC /DE/ CENTRAL INDEX KEY: 0000882484 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] OWNER IRS NUMBER: 942985696 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 BUSINESS ADDRESS: STREET 1: 475 ECCLES AVE CITY: S SAN FRANCISCO STATE: CA ZIP: 94080 MAIL ADDRESS: STREET 1: 475 ECCLES AVE CITY: S SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: O S I CORP DATE OF NAME CHANGE: 19970506 3 1 FORM 3 /------------------------------/ / OMB APPROVAL / /------------------------------/ / OMB Number:............... / / Expires:.................. / / Estimated average burden.. / / Hours per response........ / /------------------------------/ +--------+ | FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION +--------+ Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 (Print or Type Response) - -------------------------------------------------------------------------------- 1. Name and Address of Reporting Person* Ocular Sciences, Inc. ("OSI") ---------------------------------------------------------------------------- (Last) (First) (Middle) 475 Eccles Avenue ---------------------------------------------------------------------------- (Street) South San Francisco CA 94080 ---------------------------------------------------------------------------- (City) (State) (Zip) 2. Date of Event Requiring Statement (Month/Day/Year) 3/19/00 -------------- 3. IRS or Social Security Number of Reporting Person (Voluntary) -------------- 4. Issuer Name and Ticker or Trading Symbol Wesley Jessen VisionCare, Inc. ("WJ") Nasdaq - "WJCO" ----------------------------------- 5. Relationship of Reporting Person to Issuer (Check all applicable) [_] Director [_] Officer [X] 10% Owner [_] Other (give title below) (specify below) ---------------------------------------------------------------------------- 6. If Amendment, Date of Original (Month/Day/Year) ---------------------------- 7. Individual or Joint/Group Filing (Check Applicable Line) [X] Form filed by One Reporting Person [_] Form filed by More than One Reporting Person Table I--Non-Derivative Securities Beneficially Owned
- -------------------------------------------------------------------------------- 1. Title 2. Amount of 3. Ownership Form: 4. Nature of of Securities Bene- Direct (D) or Indirect Bene- Security ficially Owned Indirect (I) ficial Ownership (Instr. 4) (Instr. 4) (Instr. 5) (Instr. 5) - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- - --------------------------------------------------------------------------------
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 5(b)(v). Table II--Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
- ------------------------------------------------------------------------------------------------------------------------------------ 1. Title of Derivative 2. Date Exer- 3. Title and Amount of Securities 4. Conversion 5. Ownership 6. Nature of In- Security (Instr. 4) cisable and Underlying Derivative Security or Form of direct Bene- Expiration (Instr. 4) Exercise Derivative ficial Date Price Security: Ownership (Month/Day/ of Direct (D) (Instr. 5) Year) Derivative or In- ---------------------------------------------------- Security direct (I) Date Expira- Amount or (Instr. 5) Exer- tion Title Number of cisable Date Shares - ------------------------------------------------------------------------------------------------------------------------------------ Option (Right to Purchase) (a) (b) Common Stock 3,506,397 25.00 D (c) - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------
Explanation of Responses: (a) The option referenced above was granted in connection with an Agreement and Plan of Merger, dated March 19, 2000, among WJ, OSI and OSI Acquisition Corp. The option is not currently excercisable. The option may be exercised by OSI at any time after the occurrence of an event the result of which is that the total fee required to be paid to OSI pursuant to Section 7.2 of the merger agreement equals $20.0 million. (b) The option is scheduled to expire upon the earlier of:(i) the effective time of the merger, (ii) six months after the first occurrence of an event that entitles OSI to receive the termination fee set forth in the merger agreement, (iii) the termination of the merger agreement under circumstances in which no termination fee is payable or (iv) 12 months after the date the merger agreement is terminated if OSI is entitled to receive termination fees under Section 7.2(b)(A) thereof. (c) OSI expressly disclaims beneficial ownership of all shares of WJ Common Stock that may be purchased upon the exercise of the option. Ocular Sciences, Inc. /s/ Gregory Lichtwardt 3/28/00 ------------------------------- ----------------- **Signature of Reporting Person Date Name: Gregory Lichtwardt Title: Chief Financial Officer ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. SEC 1473 (7-96) Page 2 -----END PRIVACY-ENHANCED MESSAGE-----